In a filing, Becton Dickinson & Co revealed its Director Fraser Claire unloaded Company’s shares for reported $0.17 million on Sep 10 ’25. In the deal valued at $187.50 per share,917 shares were sold. As a result of this transaction, Fraser Claire now holds 22,226 shares worth roughly $4.14 million.
Then, Fraser Claire bought 917 shares, generating $171,862 in total proceeds.
Before that, Feld Michael sold 57 shares. Becton Dickinson & Co shares valued at $11,285 were divested by the EVP & President, Life Sciences at a price of $197.99 per share. As a result of the transaction, Feld Michael now holds 8,360 shares, worth roughly $1.56 million.
Citigroup downgraded its Becton Dickinson & Co [BDX] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Raymond James’s analysts, who decreased its forecast for the stock in early May from “an Outperform” to “a Mkt perform”. Piper Sandler also remained covering BDX and has decreased its forecast on May 02, 2025 with a “Neutral” recommendation from previously “an Overweight” rating. Goldman revised its rating on May 02, 2025. It rated BDX as “a Neutral” which previously was an “a Buy”.
Price Performance Review of BDX
On Tuesday, Becton Dickinson & Co [NYSE:BDX] saw its stock jump 0.25% to $186.21. Over the last five days, the stock has lost -2.25%. Becton Dickinson & Co shares have fallen nearly -20.93% since the year began. Nevertheless, the stocks have fallen -17.92% over the past one year.
How much short interest is there in Becton Dickinson & Co?
A steep rise in short interest was recorded in Becton Dickinson & Co stocks on 2025-08-29, dropping by -0.92 million shares to a total of 4.56 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 5.48 million shares. There was a decline of -20.15%, which implies that there is a negative sentiment for the stock.
